Document B88ov70kXE0YOBpaLXn4JkqDo

December 9, 1988 Dear Vinyl Chloride Panel Members: As decided at the November 29 conference call, Dr. Bill Gaffey has prepared the enclosed scope of work that many of the Panel companies will be requested to follow. If I receive an adequate indication of interest from the Panel to resolve the issue identified in Bill's letter, I will ask Dr. Otto Wong at Environmental Health Associates to supply you with the information pertinent to your company. Please call me at 202/887-1192 if your company will be able to provide the necessary manpower to follow up on Bill's recommendation. Wishing you happy holidays, Hasmukh C. Shah, Ph.D. Manager Vinyl Chloride Program CMA 009708 September 23, 1988 Dear Vinyl Chloride Panel Members: The conference call tentatively scheduled for September 29 or 30 is cancelled. A new date will be set up after checking with Panel members for maximum participation. Meanwhile, please review the enclosed September 15 letter from Dr. Bill Gaffey that summarizes his meeting with Dr. Brian Bennett of ICI, England. The background information leading to this meeting was sent to you earlier, but also is enclosed for your ready access. At our conference call in early October, we will discuss the EHA's interim report that was sent to you earlier and a course of action for resolving discrepancies between the EHA study and the Angiosarcoma Registry. Sincerely, Hasmukh C. Shah, Ph.D. Manager Vinyl Chloride Program cc: Vinyl Chloride Research Coordinators CMA 009709